Stocks under pressure as Trump vows to end violent protests
By Administrator_India
Asian stocks were set to come under pressure on Tuesday following a dip in Wall Street futures as U.S. President Donald Trump vowed to use force to end violent protests in American cities, souring a previously upbeat market mood.
E-mini futures for the S&P 500 fell 0.38% and {{178|Japan’s Nikkei 225 futures lost 0.34%. Australian S&P/ASX 200 futures rose 0.15% in early trading.
The early indications came after major U.S. stock indexes closed with gains of about 0.5% and continued to hover near three-month highs.
As Trump spoke in the Rose Garden of the White House on Monday, live television images showed police firing tear gas to dispel demonstrators in Lafayette Park, across the street.
As Asian markets prepared to open, dozens of cities across the United States were under curfews with the National Guard deployed in 23 states and Washington, D.C.
The curfews followed protests over the death of George Floyd, a 46-year-old African American who died in Minneapolis after being pinned beneath a white police officer’s knee for nearly nine minutes.
The dollar index fell 0.4%, as risk appetite had increased on optimism that the worst of the global economic downturn caused by the coronavirus may be in the past.
The biggest concern for bond markets was growing U.S. government debt with the benchmark 10-year Treasury notes yield rising to 0.677% from 0.644% on Friday.
Similarly, in the eurozone, the IHS Markit’s Manufacturing Purchasing Managers’ Index recovered slightly in May from April’s record low, although factory activity still contracted heavily.
Oil futures steadied on Monday despite U.S.-China trade tensions with Brent up 1.3% to settle at $38.32 a barrel and U.S. crude slipping 5 cents to $35.44 a barrel.
Spot gold added 0.8% to $1,739.75 an ounce. U.S. gold futures gained 0.03% to $1,737.40 an ounce.
In the trade dispute, sources in China said the government had told them to halt purchases of U.S. soybeans after Trump moved to eliminate special treatment for Hong Kong to punish Beijing over its new security laws for the city.
Though investors are closely watching for news on medical advances against the pandemic, to markets took in stride mixed news from Gilead Sciences Inc, whose shares fell about 4%. Gilead said that its antiviral drug remdesivir provided a modest benefit in patients with moderate COVID-19 given a five-day course of the treatment, while those who received the medicine for 10 days in the study did not fare as well.
